A case of anti-MOG antibody-positive multiphasic disseminated encephalomyelitis co-occurring with unilateral cerebral cortical encephalitis

Clinical Neurology

Volumn 57, Issue 11, 2017, Pages 723-728

  Fukushima, Naoya ^a   Suzuki, Miki ^a   Ogawa, Ryo ^b   Hayashi, Kitami ^a   Takanashi, Jun Ichi ^a   Ohashi, Takashi ^a  

^a Tokyo Women s Medical University   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti MOG Antibody; Encephalitis; Epileptic Seizure; Magnetic Resonance Spectroscopy; Multiphasic Disseminated Encephalomyelitis

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AUTOANTIBODY; BIOLOGICAL MARKER; MOG PROTEIN, HUMAN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BRAIN CORTEX; CASE REPORT; CLINICAL ARTICLE; ENCEPHALOMYELITIS; FEMALE; HUMAN; MULTIFOCAL DISSEMINATED ENCEPHALOMYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; SEIZURE; UNILATERAL CEREBRAL CORTICAL ENCEPHALITIS; YOUNG ADULT; BLOOD; COMPLICATION; ENCEPHALITIS; IMMUNOLOGY; NEUROIMAGING;

AUTOANTIBODIES; BIOMARKERS; CEREBRAL CORTEX; ENCEPHALITIS; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROIMAGING; YOUNG ADULT;

EID: 85036504271     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.cn-001078     Document Type: Article

References (23)

1. Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: Current understanding and controversies. Semin Neurol 2008;28:84-94.
2. Pohl D, Alper G, Van Haren K, et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology 2016;87(9 Suppl 2):S38-S45.
3. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler 2013;19:1261-1267.
4. Reindl M, Di Pauli F, Rostásy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013;9:455-461.
5. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014;82:474-481.
6. Ogawa R, Nakashima I, Takahashi T, et al. MOG antibodypositive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 2017;4:e322.
7. Bernard CC, Johns TG, Slavin A, et al. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis. J Mol Med (Berl) 1997;75:77-88.
8. Iglesias A, Bauer J, Litzenburger T, et al. T-A nd B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001;36:220-234.
9. Kuhle J, Pohl C, Mehling M, et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 2007;356:371-378.
10. Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 2009;66:833-842.
11. Probstel AK, Dornmair K, Bittner R, et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011;77:580-588.
12. Ketelslegers IA, Van Pelt DE, Bryde S, et al. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort. Mult Scler 2015;21:1513-1520.
13. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 2015;86:265-272.
14. Kim SM, Woodhall MR, Kim JS, et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2015;2:e163.
15. Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study. Neurology 2010;75:208-216.
16. Ikeda K, Kiyota N, Kuroda H, et al. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Mult Scler 2015;21:656-659.
17. Zamvil SS, Slavin AJ. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder Neurol Neuroimmunol Neuroinflamm 2015; 2:e62.
18. Ben Sira L, Miller E, Artzi M, et al. 1H-MRS for the diagnosis of acute disseminated encephalomyelitis: Insight into the acutedisease stage. Pediatr Radiol 2010;40:106-113.
19. Cianfoni A, Caulo M, Cerase A, et al. Seizure-induced brain lesions: A wide spectrum of variably reversible MRI abnormalities. Eur J Radiol 2013;82:1964-1972.
20. Titulaer MJ, Höftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;75:411-428.
21. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
22. Numa S, Kasai T, Kondo T, et al. An adult case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated multiphasic acute disseminated encephalomyelitis at 33-year intervals. Intern Med 2016;55:699-702.
23. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.